In the context of continuous development with new generation medical equipment, ANASSA acquired the Xpert Xpress Flu/RSV molecular diagnosis system >, which enables healthcare providers to control infections through instant patient information and rapid management. More specifically, it has the following advantages:
- Direct molecular diagnosis of Influenza A – Influenza B – Syncytial virus
- Providing results in 30′
- Detects 49 strains of Influenza and 5 RSV
- Sensitivity that reaches 99%
- Simple and painless sampling
Contact phone: 2421 316472
Σας βοήθησε αυτό το άρθρο;
ΝαιΌχι